Safety And Efficacy Of The ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2: An Interim Analysis Of Four Randomised Controlled Trials In Brazil, South Africa, And The UK

·2021·DOI

Role in the Field

Abstract

Citations

3,090

Year

2021

PageRank

4.6 / 10

Relative influence (log-scaled)

Safety And Efficacy Of The ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2: An Interim Analysis Of Four Randomised Controlled Trials In Brazil, South Africa, And The UK | Manumap